1346809-61-7 Usage
General Description
7H-Pyrrolo[3,4-b]pyridin-7-one, 3-bromo-5,6-dihydro- is a chemical compound with a pyrrolopyridine structure containing a bromine atom. It is a heterocyclic compound with potential pharmaceutical applications due to its diverse pharmacological activities, including anti-inflammatory, anti-cancer, and anti-bacterial properties. 7H-Pyrrolo[3,4-b]pyridin-7-one, 3-bromo-5,6-dihydro- has been studied for its potential as a drug candidate for various diseases and disorders. Its unique structure and biological activities make it a valuable target for further research and development in the field of medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1346809-61-7 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,6,8,0 and 9 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1346809-61:
(9*1)+(8*3)+(7*4)+(6*6)+(5*8)+(4*0)+(3*9)+(2*6)+(1*1)=177
177 % 10 = 7
So 1346809-61-7 is a valid CAS Registry Number.
1346809-61-7Relevant articles and documents
BENZAZEPINE DERIVATIVE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF
-
Paragraph 0170; 0173; 0174, (2019/03/29)
Disclosed are a benzazepine derivative, a preparation method, a pharmaceutical composition and the use thereof. A compound as shown in formula (I) of the present invention, and an isomer, a prodrug, a stable isotope derivative or a pharmaceutically acceptable salt thereof have the following structure. The benzazepine derivative of the present invention has a good regulation effect on the TLR family and the related signalling pathway, and in particular, has a good regulation effect on TLR8, can effectively treat, relieve and/or prevent various diseases mediated by TLR family and the TLR-related signalling pathway, and in particular, can effectively treat, relieve and/or prevent various diseases mediated by TLR8, such as cancers, autoimmune diseases, infections, inflammations, transplantation rejections, graft-versus-host diseases, etc.